2-[(1R,4S,7S,13S,19R,22S,25S,28R,34S,37S,40S)-25-(4-aminobutyl)-22-(1H-indol-3-ylmethyl)-4-methyl-2,5,8,14,20,23,26,29,32,35,38,41-dodecaoxo-7,34,40-tris(propan-2-yl)-44,45-dithia-3,6,9,15,21,24,27,30,33,36,39,42-dodecaazatetracyclo[26.14.4.0^{9,13}.0^{15,19}]hexatetracontan-37-yl]acetic acid

ID: ALA2022288

Chembl Id: CHEMBL2022288

PubChem CID: 70696058

Max Phase: Preclinical

Molecular Formula: C57H84N14O14S2

Molecular Weight: 1253.52

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](CCCCN)C(=O)N2

Standard InChI:  InChI=1S/C57H84N14O14S2/c1-28(2)44-54(82)64-37(23-43(73)74)51(79)68-45(29(3)4)55(83)66-39-27-87-86-26-38(48(76)60-25-42(72)67-44)65-49(77)35(16-10-11-19-58)62-50(78)36(22-32-24-59-34-15-9-8-14-33(32)34)63-53(81)40-17-12-20-70(40)56(84)41-18-13-21-71(41)57(85)46(30(5)6)69-47(75)31(7)61-52(39)80/h8-9,14-15,24,28-31,35-41,44-46,59H,10-13,16-23,25-27,58H2,1-7H3,(H,60,76)(H,61,80)(H,62,78)(H,63,81)(H,64,82)(H,65,77)(H,66,83)(H,67,72)(H,68,79)(H,69,75)(H,73,74)/t31-,35-,36-,37-,38-,39-,40+,41-,44-,45-,46-/m0/s1

Standard InChI Key:  KBCBCNPPSIOJFP-CUDHCHDXSA-N

Associated Targets(Human)

VWF Tclin von Willebrand factor (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1253.52Molecular Weight (Monoisotopic): 1252.5733AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Bernard E, Buckley V, Moman E, Coleman L, Meade G, Kenny D, Devocelle M..  (2012)  Inhibition of platelet adhesion by peptidomimetics mimicking the interactive β-hairpin of glycoprotein Ibα.,  22  (9): [PMID:22460035] [10.1016/j.bmcl.2012.03.022]

Source